Skip to main content
Log in

Fecal microbiota transplant cost effective for recurrent CDI in IBD

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2019 US dollars

  2. recurrent CDI

Reference

  • You JHS, et al. Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease. Journal of Gastroenterology and Hepatology : 3 Feb 2020. Available from: URL: http://doi.org/10.1111/jgh.15002

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fecal microbiota transplant cost effective for recurrent CDI in IBD. PharmacoEcon Outcomes News 847, 11 (2020). https://doi.org/10.1007/s40274-020-6587-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6587-x

Navigation